Key Sessions
Ryan Richardson
The Future of Funding: Emerging Trends in Life Sciences Investments
BioNTech
Aradhana Sarin
Challenges and Opportunities for Biopharma in 2025
AstraZeneca
Monika Vnuk
Mastering Pharma Deals: Strategies for Effective Transactions Across Top Therapeutic Areas
Sanofi
Stephen Ranjan
Easing The Burden on Patients – Human Centric AI Design in Clinical Trials
Roche
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day Two - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day Two - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Formats
08:00 - 09:00
Registration & Breakfast
Showing 3 of 3 Streams
Biotech Leaders Morning Keynote Plenary
Medtech Leaders
Healthtech Leaders
09:00 - 09:05
LSX Welcome Address
- Adam Griffiths - Portfolio Manager, LSX
09:05 - 09:45
Challenges and Opportunities for Biopharma in 2025
- Aradhana Sarin - Executive Director & Chief Financial Officer, AstraZeneca
- Maha Radhakrishnan - Executive Partner, Sofinnova Investments
09:45 - 10:30
Mastering Pharma Deals: Strategies for Effective Transactions Across Top Therapeutic Areas
- Monika Vnuk - SVP, Global Partnering & Business Development, Sanofi
- Kristine Dorward - Corporate and Business Development Consultant, Pullan Consulting
- Evan Lippman - EVP, Business Development, Teva Pharmaceuticals
- Nerida Scott - Head of Johnson & Johnson Innovation EMEA, Johnson & Johnson Innovation
- Hannah England - Partner, Ropes & Gray
- Matthias Müllenbeck - SVP, Head Global BD & Alliance Management, Merck KGaA
09:00 - 09:10
LSX Welcome Address: MedTech Leaders
- Jack Giles - Conference Producer, LSX
09:10 - 09:50
More Than Just a Seat at the Table: an Overview of Women in Medtech, What More Needs to be Done?
- Marissa Fayer - CEO, DeepLook Medical
- Umaima Ahmad - CEO & Co-founder, 52 North Health
- Joana Cartocci - Co-founder & COO, Robeauté
- Jennifer Hoffman - Founder, Unstoppable
09:00 - 09:10
LSX Welcome Address: HealthTech Leaders
- Nadia Konneh - Senior Conference Director, Healthtech Lead, LSX
09:10 - 09:50
Easing The Burden on Patients – Human Centric AI Design in Clinical Trials
- Stephen Ranjan - Global Head of Digital Health, Roche
- Christian Hein - Board Member, QuantHealth
- Jen Berkeley - Design Director, Frog UK
- Suki Balendra - Director of Strategic Partnerships, Imperial College Healthcare NHS Trust (Paddington Life Sciences)
- Shrawan Patel - Co-founder & Head Mentor Advisor, PharmStars
- Simon Pulman-Jones - Head of Design, Patient Solutions, Evinova
09:50 - 10:30
Integration & Adoption of Digital Health Innovation into Healthcare Systems
- Devika Rani Wood - CEO, Brain+
- Yacine Hadjiat - Innovation in Health Science & Digital Health, Dubai Health
- Heather Cook - CEO, Wellmind Health
- Anna Loughran - Director, Product Management, Digital Health, International Markets, BMS
- Claire Oatway - CEO, neon juno
10:30 - 11:10
Morning Break
Showing 6 of 6 Streams
LSX Masterclasses
Biotech Leaders - Capital Markets & Investment
Biotech Leaders - Partnerships & Deal Making
Biotech Leaders - Scaling & Commercialisation
Medtech Leaders
Healthtech Leaders
11:10 - 11:55
IP Masterclass - Medtech Focus
IP Masterclass - Medtech Focus
- Part 1: Building an Effective IP Portfolio
- Overview from C&R IP experts covering:
- Available forms of protection for Medtech companies including overlooked forms of IP
- IP strategy considerations (budgets, geography, markets, commercial objectives) for start-ups and scale-ups: Allocation of resources and cost-effectiveness
- Specific IP challenges and opportunities facing the Medtech sector
- Options for enforcement of IP in Europe
- Overview from C&R IP experts covering:
- Part 2: Case study
- Part 3 leading into Lunch: Q&A
- Q&A session allowing the opportunity for small-group discussion with C&R IP experts.
- The discussion will break out into different individual topic groups, which participants are free to join.
- Each topic group will pick up a theme from Part 1 of the session, so participants can explore the topic which they feel is most relevant to them.
- Experts from C&R will be available over lunch to continue the discussion with participants, either in small groups or 1-to-1.
- Aidan Crawley - Co-Founder & CEO, Amber Therapeutics
- Paul Bettridge - Partner, Carpmaels & Ransford
- John Brunner - Partner and Engineering & Tech Practice Leader, Carpmaels & Ransford
- Ben Chapman - Patent Attorney, Carpmaels & Ransford
11:10 - 12:00
The Big Biotech IPO: Charting a Path Through Opportunities and Challenges
- Dirk Kersten - General Partner, Forbion
- John Rudy - Member / Co-chair, Securities & Capital Markets Practice, Mintz
- Alastair Kilgour - Founder, Parkwalk Advisors
- Max Klement - Partner, Venture Investments, Novo Holdings
12:00 - 12:50
Leveraging Debt for Growth: Financing the Future of Biotech Innovation
- Tassos Konstantinou - Managing Director, Life Sciences, SPRIM Global Investments
- Aris Constantinides - Managing Director, BlackRock
11:10 - 11:50
Early Bird Gets the Deal? Pioneering Early for to Advance Therapeutic Innovation
- Irene Pasquali - Head of Global BD, Respiratory, Chiesi
- Khatereh Ahmadi - Executive Director, MSD
- Millie Nelson - Editor, Partnering, Informa Connect Life Sciences
- Nuno Alves - Associate Director, Business Development, Astellas
- Andrew Crockford - Director, Early Innovation Partnering - Oncology (EMEA), Johnson & Johnson
- Sam Black - Director BD&L, Merck Group
11:50 - 12:10
How to Enter Into an Exclusive Option and License Agreement with a Large Pharma
- Ingo Lehrke - CBO, Tubulis
12:10 - 12:50
Biotech/Pharma Spin-Outs: Investment Strategies in Advancing Characterized Assets
- Björn Cochlovius - CEO, eleva
- David Danovitch - Partner, Sullivan & Worcester
- Pierre-Louis Joffrin - Associate Partner, Syncona
- Tim Dyer - CEO, Addex and Neurosterix
- Lukas Linnig - Founder & Co-CEO, Akribion Therapeutics
- Andrew Round - Investment Director, Deepbridge Capital
12:00 - 12:50
Aligning Vision and Execution: What Board Members Expect from Biotech Leadership
- Edwin Moses - Chairman of the Board, Avantium NV, LabGenius Ltd., NanoSyrinx Ltd., Dark Blue Therapeutics Ltd.
- Mette Agger - Advisor & CEO, Esrum Biotech
- Jane Rhodes - CEO, AstronauTx
- Piers Morgan - CFO, Pangea Bio
- Linda McGoldrick Ph.D - Board Director, Alvotech
- Hakan Goker - Executive Investment Director, M Ventures
11:10 - 11:50
(Clinical) Trials and Tribulations: The Benefits of Effective Clinical Investigation Planning
- Valentina Milanova - Founder & CEO, Daye
- Christopher Allen - Investor, Gilde Healthcare
- Ariana Adjani - Governor at Oxford University Hospitals NHS Foundation Trust and Co-Founder & Managing Director, FINE TREATMENT
- Manu Vohra - Managing Director, Box
12:10 - 12:50
How is Artificial Intelligence Revolutionising the Medtech Space?
- Marina Massingham - Executive Chair, Aifred Health
- Stephanie Kuku - Chief Knowledge Officer, Conceivable Life Sciences
- James Wong - Ventures Senior Portfolio Manager, Foresight Group
- Jan Beger - Global Head of AI Advocacy, GE HealthCare
- Wim Van Hecke - CEO, icometrix
- James Pink - Senior Director – Medical, Element Materials Technology
11:10 - 11:30
People vs Computers: Artificial Intelligence vs Actual Intelligence
- Mike Trenell - CEO & Co-Founder, Daiser
- Prof Pearse Keane - Professor of Artificial Medical Intelligence, UCL
11:30 - 12:10
Is the AI Craze Distorting the VC Market?
- Yara Alenazi - Investor, HealthTech, MassMutual Ventures
- Tony Cheng-Fu Chang - Director, Healthtech, BII
- Diana Röttger - Principal, APEX Ventures
- Marko Kuisma - Partner, Innovestor
12:10 - 12:50
Integrating Digital Health & DTx Solutions into Pharma
- Hakim Yadi - CEO & Co-Founder, Closed Loop Medicine
- Gregoire Guillet - Chief Business and Value Officer, WeHealth Digital Medicine, Servier
- David Benshoof Klein - Founder & CEO, Click Therapeutics
- Dominic James - Founder & CEO, Future Centric
- Baudouin Hue - Partner, Karista
- Marc Sluijs - Founder, DigitalHealth.Network
12:50 - 14:00
Lunch Break
Showing 3 of 3 Streams
Biotech Leaders Afternoon Keynote Plenary
Medtech Leaders
Healthtech Leaders
14:00 - 15:00
Thriving Amidst Turbulence: Building Resilience in Life Sciences
- Jeremy Skillington - CEO, Poolbeg Pharma
- Vladimir Cmiljanovic - Chairman and CEO, Swiss Rockets AG
- Klaus Stöckemann - Managing Director & Co-Founder, Peppermint Venture Partners
- Gautam Kainth - Partner, TCP Health Ventures
- Laurent Pacheco - Managing Partner, International Family Office Alliance for Health
15:00 - 16:00
The Future of Funding: Emerging Trends in Life Sciences Investments
- Ryan Richardson - Chief Strategy Officer, BioNTech
- Laurence Barker - Partner - DDF, SV Health Investors
- Julie Pelrine - Partner, CFGI
- Magdalena Jonika - Lead Partner, Syncona
- Edward van Wezel - Managing Partner, Biogeneration Ventures
14:00 - 14:40
Diversifying Revenue Streams: Friend or Foe?
- Joacim Holter - CEO, Lifecare AS
- Nicholas Ibery - Venture Capital Investor, NLC Ventures
- Lauren Edison - Investment Director, Apposite Capital
- Laurent Pacheco - Managing Partner, International Family Office Alliance for Health
14:40 - 15:20
Unlocking the NHS: A Roadmap for Medtech Adoption in the National Health Service
- Vladimir Gubala - Chief Scientific Officer & Co-founder, PocDoc
- Konrad Dobschuetz - Former National Director, Former NHS Innovation Accelerator
- Yasemin Arik - Partner, G Square Healthcare Private Equity
- John Milad - CEO, ERS Genomics
- Matthew Neal - Partner & Head of Life Sciences, 5654 & Company
15:20 - 16:00
University Challenge: The Role of Universities in the European Medtech Landscape
- Lotus Qi - Head of MedTech, Capital Enterprise
- Daniel Green - Fellow in Entrepreneurship, Imperial College London
- Emilie Syed - Principal, Health of People, Zinc
- Anne Dobrée - Investment Director, Parkwalk Advisors
- Laurens de Vries - Venture Capital Analyst, Heran Partners
14:00 - 14:40
Anticipating the Global Impact of the EU AI Act – What Does it Mean for Investment, Innovation & Care?
- Sridevi Nagarajan - Former Global Head Digital Regulatory Strategy, Independent
- Leon Doorn - Chair Medical Device / AI Working Group, NEN (Dutch Standardisation Institute)
- Shona D'Arcy - Entrepreneurship Lead, EIT Health
- Fernando Benito - CTO & Co-Founder, Custom Surgical
14:40 - 15:20
Care at Home - Increasing Healthcare Accessibility, Convenience & Burden on Hospitals
- Marie-Louise Little - Director of Strategy & Business Development, TW Medical A/S (Family Office)
- Ventsislav Dobrev - Global Lead Digital Health, Ypsomed AG
- Francesca Markland - Senior Programme Manager for Remote Monitoring & Virtual Wards, NHS England
- Chris Malone - UK Managing Director, Luscii
- Toby Basey-Fisher - CEO, Entia
15:20 - 16:00
Data & Trust – Managing Data Transparently in Digital Health
- Avi Mehra - Associate Partner & CSO – Healthtech, IBM
- Tuomo Pentikäinen - CEO, Veil.AI
- Anna Wojnarowska - Staff UX Researcher & Manager, Google
- Liz Ashall-Payne - CEO, ORCHA
- Victor Barzey - Product Lead, Digital Healthcare, Otsuka
- Jhonatan Bringas Dimitriades - Chief Executive Officer & Co-Founder, Lapsi Health
16:00 - 16:05
Close of Congress
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats